Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia
NCT ID: NCT06852859
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2025-03-15
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to investigate in great detail patients' recovery after surgery for BPH regarding pain, hematuria, urine leakage and use of pain-relieving medications for three months postoperatively. Patient-reported outcomes after three different surgical methods will be investigated: transurethral resection, transurethral vaporization and laser transurethral enucleation of the prostate (Green-LEP)
Research questions:
* How do patients rate their day-to-day pain during the first three months after surgery for BPH? How long does it take to be pain free?
* How does the patient estimate any day-to-day burning sensation during the first three months after surgery for BPH?
* How many painkilling tablets of a certain preparation and a certain strength take patients per day in the first three months after surgery for BPH?
* How long do patients have urinary leakage after surgery for BPH?
* Are the patients bothered by possible urine leakage and if so for how long after surgery for BPH?
* How long does one have macroscopic hematuria after surgery for BPH?
* How quickly are the patients' urinary tract problems affected according to the IPSS per month?
* Are the results on the above outcome measures different between the three TUR-P methods, TUV-P and Green LEP?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients
NCT02075736
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919
MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)
NCT03131544
KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)
NCT02011308
Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH
NCT01218672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective multicenter observational study in which patients undergoing TUR-P, TUV-P and GreenLEP for BPH are included. The subjects will be followed up with a self-assessment form that is completed daily for three months and then sent to the responsible researchers. After this, the research subjects will be followed up with sent out IPSS forms after six months, and then annually for up to five years. These are sent in stamped envelopes.
Participants:
The study will include 500 patients who undergo surgery for BPH at Alingsås hospital, Sjukhusen i Väster and Sahlgrenska University Hospital, as well as possibly an additional urology clinic in the future. The inclusion criteria include men over 50 years of age with diagnosed BPH and LUTS who have an indication for surgery with any of the three methods studied.
Outcome measures:
1. Pain and burning will be assessed using the NRS (numeric scale) between 0 and 10 where 0 is defined as "no pain/burning" and 10 is defined as "worst imaginable pain/burning". The researchers fill in this day-by-day for three months
2. Use of pain-relieving medications will be investigated with a table in which the research subjects enter drug names and sum up the number of tablets taken per day.
3. Urine leakage will be examined by the research subjects checking either "Yes" or "no" on the question of whether they have had urine leakage on a daily basis.
4. If this urine leakage has bothered the research subjects, it is investigated by ticking either "Yes" or "No" daily as a follow-up question to the previous one.
5. The duration of hematuria will be examined by the research subjects checking either "Yes" or "No" on the question of whether they have had blood in the urine daily
6. The change in LUTS measured by IPSS will be used to measure patient-perceived outcomes at baseline, after four, eight and twelve weeks, after six months and then annually for five years.
Data Analysis:
Descriptive statistics will be used to compile the PROMs data. Changes over time will be analyzed using repeated measures (ANOVA). Differences in outcome measures between the three different methods will be analyzed with the Mann-Whitney test for continuous, independent data pairs, and the Chi-Square test for categorical variables.
Ethical considerations:
The study will be conducted in accordance with the Declaration of Helsinki, and all participants will give their informed consent. Ethical approval will be sought from the Ethical Review Authority (EPM)
Significance and clinical relevance:
The results of this study will provide important insights into how patient-reported outcomes after benign prostate surgery can be used to improve surgical outcomes and patient counseling. The results will also be able to be used to compare outcome measures between the three different treatments used for BPH. By highlighting the patient's perspective, care can be developed to better meet the patients' needs and expectations, and by determining a "normal course" regarding these outcome measures, the results can also be used in the future to identify patients who deviate from the expected recovery course.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient treated by transurethral surgical procedure
Patients treated for BPH with surgery
Transurethral resection of the prostate
Thermocoagulation is used in contrast to the other methods
Transurethral vaporization of the prostate
Heat is used to vaporize prostate
GreenLight laser enucleation of the prostate
laser is used in contrast to the other methods
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transurethral resection of the prostate
Thermocoagulation is used in contrast to the other methods
Transurethral vaporization of the prostate
Heat is used to vaporize prostate
GreenLight laser enucleation of the prostate
laser is used in contrast to the other methods
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singed informed consent to participate
Exclusion Criteria
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vastra Gotaland Region
OTHER_GOV
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joakim Stromberg
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joakim BE Strömberg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alingsås lasarett, department of general surgery, urology and orthopaedic surgery
Alingsås, , Sweden
Kungälvs sjukhus, department of urology
Kungälv, , Sweden
NU sjukvården, Uddevalla sjukhus, department of urology
Uddevalla, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-06211-01 EPM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.